ChemicalBook >> CAS DataBase List >>MDA 19

MDA 19

CAS No.
1048973-47-2
Chemical Name:
MDA 19
Synonyms
MDA 19;MDA19; MDA-19;N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide;(Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide;N-[(Z)-(1-Hexyl-2-oxo-indolin-3-ylidene)aMino]benzaMide;N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide;Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide;MDA 19 (Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide
CBNumber:
CB12535682
Molecular Formula:
C21H23N3O2
Molecular Weight:
349.43
MDL Number:
MFCD18428001
MOL File:
1048973-47-2.mol
Last updated:2023-05-21 10:59:17

MDA 19 Properties

Density 1.16±0.1 g/cm3 (20 ºC 760 Torr)
storage temp. Store at -20°C
solubility DMF: 20 mg/ml; DMSO: 10 mg/ml; Ethanol: 3 mg/ml; Methanol: 1 mg/ml
form A crystalline solid
pka 10.45±0.20(Predicted)
FDA UNII X83OI5CX2U

MDA 19 Chemical Properties,Uses,Production

Uses

MDA 19 is a selective agonist of the human peripheral cannabinoid (CB2) receptor. A cell-based functional assay showed MDA is an inverse agonist of the CB2 receptor in rat. Acts as an inverse agonist at the rat CB2 receptor. Reported Ki values are 16.3 and 1130 nM for human CB2 and CB1 receptor respectively. MDA19 was effective in attenuating tactile allodynia in neuropathic rats. MDA19 thus has potential for alleviating neuropathic pain without producing adverse effects in the central nervous system.Synthetic Cannabinoids

MDA 19 Preparation Products And Raw materials

Raw materials

Preparation Products

(Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide MDA 19 (Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide MDA 19 N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide N-[(Z)-(1-Hexyl-2-oxo-indolin-3-ylidene)aMino]benzaMide MDA19; MDA-19 1048973-47-2